These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10346681)

  • 21. Conflicts of interest in medical research: how much conflict should exceed legal boundaries?
    Klanica K
    J Biolaw Bus; 2005; 8(3):37-45. PubMed ID: 16459426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conflicts of interest.
    Nature; 1989 Aug; 340(6236):664. PubMed ID: 11644385
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA issues concerning conflicts of interest.
    Kurt TL
    IRB; 1990; 12(5):6-9. PubMed ID: 11654003
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical device labeling and advertising: an overview.
    Basile EM; Armentrout E; Reeves KN
    Food Drug Law J; 1999; 54(4):519-33. PubMed ID: 11824451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Financial conflict of interest in medical research: overview and analysis of federal and state controls.
    Henderson JA; Smith JJ
    Food Drug Law J; 2002; 57(3):445-56. PubMed ID: 12710405
    [No Abstract]   [Full Text] [Related]  

  • 26. Kiss and make-up: a need for consolidation of FDA and cosmetic industry regulation programs.
    Mason DE
    Health Matrix Clevel; 2008; 18(1):181-207. PubMed ID: 19161130
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA's counsel accused of being too close to drug industry.
    Lenzer J
    BMJ; 2004 Jul; 329(7459):189. PubMed ID: 15271811
    [No Abstract]   [Full Text] [Related]  

  • 28. Medical devices; hearing aids; technical data amendments. Direct final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2008 Jun; 73(106):31358-60. PubMed ID: 18677822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Federal agency revises rule on financial disclosure by researchers.
    Maloney DM
    Hum Res Rep; 1999 Feb; 14(2):1-2. PubMed ID: 11657602
    [No Abstract]   [Full Text] [Related]  

  • 30. Is it worth the trouble? The new policy on dissemination of information on off-label drug use under the Food and Drug Administration Modernization Act of 1997.
    Weeks EA
    Food Drug Law J; 1999; 54(4):645-65. PubMed ID: 11824459
    [No Abstract]   [Full Text] [Related]  

  • 31. Virus.
    Bazell R
    New Repub; 1992 Nov; 207(20):21-2. PubMed ID: 11659543
    [No Abstract]   [Full Text] [Related]  

  • 32. Public-private partnerships in biomedical research: resolving conflicts arising under the Federal Technology Transfer Act of 1986.
    Bulleit TN
    J Law Health; 1989-1990; 4(1):1-20. PubMed ID: 11652568
    [No Abstract]   [Full Text] [Related]  

  • 33. Ingrown toenail relief drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 May; 68(88):24347-9. PubMed ID: 12737160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Guidance for industry: content and format of chemistry, manufacturing and controls information and establishment description information for a biological in vitro diagnostic product;" availability. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(44):11023-4. PubMed ID: 10557623
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Additional criteria and procedures for classifying over-the-counter drugs as generally recognized as safe and effective and not misbranded. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(15):3060-76. PubMed ID: 11820251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA's new rule on treatment use and sale of investigational new drugs.
    Levine RJ
    IRB; 1987; 9(4):1-4. PubMed ID: 11649946
    [No Abstract]   [Full Text] [Related]  

  • 37. Financial disclosures of scientific papers presented at the 2003 RSNA Annual Meeting: association with reporting of non-Food and Drug Administration-approved uses of industry products.
    Brown SD; Daly JC; Kalish LA; McDaniel SA
    Radiology; 2006 Jun; 239(3):849-55. PubMed ID: 16641343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor reports dog industry-academia liaison.
    Ready T
    Nat Med; 2002 Dec; 8(12):1338-9. PubMed ID: 15085880
    [No Abstract]   [Full Text] [Related]  

  • 39. Criminal liability for misconduct in scientific research.
    Kuzma SM
    Univ Mich J Law Reform; 1992; 25(2):357-421. PubMed ID: 11651584
    [No Abstract]   [Full Text] [Related]  

  • 40. Is Noerr-Pennington immunity still a viable defense against antitrust claims arising from Hatch-Waxman litigation?
    Steinhauer EH
    Food Drug Law J; 2006; 61(4):679-700. PubMed ID: 17180769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.